3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
15
Active not recruiting
5
Withdrawn
3
Unknown
3
Recruiting
2
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
4
Breast
3
Thoracic
2
Other solid neoplasm
1
Other hematologic neoplasm
1
Gynecologic
1
Conditions
Hereditary Breast and Ovarian Cancer Syndrome
1
Breast Neoplasms
1
Interventions
Paclitaxel
24
Carboplatin
18
Bevacizumab
14
Cisplatin
10
pembrolizumab
7
fluzoparib
7
Radiotherapy
6
Drug Therapy
6
apatinib
5
Topotecan
5
Magnetic Resonance Spectroscopy
5
Injections
5
liposomal doxorubicin
4
lenvatinib
4
famitinib
4
camrelizumab
4
Tirzepatide
4
Specimen Handling
4
Platinum
4
Observation
4
Gemcitabine
4
Brachytherapy
4
toripalimab
3
olaparib
3
dostarlimab
3
anlotinib
3
Watchful Waiting
3
Therapeutics
3
Surveys and Questionnaires
3
Neoadjuvant Therapy
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Methods
×
Gynecologic
×
Clear all
NCT07236359
2025-11-19
Reborn-i
Beaumont Hospital
Phase NA
Not yet recruiting
108 enrolled